TCR-based Therapies for Solid Tumors Summit 2022

Temi della conferenza
Advancing Engineered, Native & Bispecific TCRs to Effectively Treat Solid Tumors
Do you want to gain unrivalled industry knowledge to build a first-class TCR-based therapy with high efficacy and targeting power in solid tumors?

Professional congress organizer (PCO)
Hanson Wade

https://go.evvnt.com/1029444-2?pid=4832

Ms. Rhianna Price